← Leaderboards
Matthew Scarpelli
Purdue University
$1,094,647
Attributed
$1,094,647
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $381.5K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,094,647 · 1
By mechanism
R01$1,094,647 · 1
Top collaborators
No co-investigators on record.
Most similar at Purdue University
Same institution · by research overlap
- Jonathan Henry Shannahan$3,130,076
- Brandon Keehn$1,010,013
- Fang Huang$5,090,032
- Alexander Chubykin$4,070,031
Others in their field
Other Rising Stars on “Anti-Tumor Immune Response”
- Dmitriy Zamarin · Sloan-Kettering Inst Can Research$3,530,063
- Mark Yarchoan · Johns Hopkins University$3,378,705
- Debattama Rai Sen · Massachusetts General Hospital$2,502,000
- Arta Monir Monjazeb · University Of California At Davis$2,398,453
- Megan K Ruhland · Oregon Health & Science University$2,265,578
- John James Blazeck · Georgia Institute Of Technology$2,260,963
Research focus
Anti-Tumor Immune ResponseBurden Of IllnessCanis FamiliarisBrain NeoplasmsCellsClinically RelevantClinical TranslationCoculture TechniquesComb Animal StructureCaringCytotoxicDesignEffectivenessEnsureFda ApprovedFerumoxytolFractionated RadiotherapyGlioblastomaGliomaImaging AgentImmunologic StimulationCompanionsImmunosuppressive MacrophagesImproved Outcome
Grant awards (3)
Improving glioma radiotherapy by theragnostic targeting of tumor-supporting macrophages$343,172
R01 · FY2025 · NS · contact PI
Improving glioma radiotherapy by theragnostic targeting of tumor-supporting macrophages$369,981
R01 · FY2024 · NS · contact PI
Improving glioma radiotherapy by theragnostic targeting of tumor-supporting macrophages$381,494
R01 · FY2023 · NS · contact PI